Page last updated: 2024-10-24

chlorambucil and Porphyrias

chlorambucil has been researched along with Porphyrias in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Palma-Carlos, AG1
Palma-Carlos, ML1
Martins-Silva, JA1

Other Studies

1 other study available for chlorambucil and Porphyrias

ArticleYear
Effect of alkylating agents on haem metabolism.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1971, Sep-25

    Topics: Adenosine Triphosphate; Alkylating Agents; Animals; Busulfan; Chlorambucil; Cyclophosphamide; Feces;

1971